{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:20:23Z","timestamp":1790248823856,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T00:00:00Z","timestamp":1536796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Institutes of Health grant from the National Institute for Neurological Diseases and Stroke","award":["R44NS095423"],"award-info":[{"award-number":["R44NS095423"]}]},{"name":"National Institutes of Health grant from the National Institute for Arthritis and Musculoskeletal and Skin Diseases","award":["1U34AR068616"],"award-info":[{"award-number":["1U34AR068616"]}]},{"name":"National Institutes of Health grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development","award":["5U54HD090254"],"award-info":[{"award-number":["5U54HD090254"]}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","award":["W81XWH-15-1-0265"],"award-info":[{"award-number":["W81XWH-15-1-0265"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA353094"],"award-info":[{"award-number":["MDA353094"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.phrs.2018.09.007","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T14:33:14Z","timestamp":1536849194000},"page":"140-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"special_numbering":"C","title":["Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug"],"prefix":"10.1016","volume":"136","author":[{"given":"Laurie S.","family":"Conklin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse M.","family":"Damsker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Jusko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panteleimon D.","family":"Mavroudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel J.","family":"Mengle-Gaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0073-9377","authenticated-orcid":false,"given":"Edward C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5795-9955","authenticated-orcid":false,"given":"Jean K.","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Guglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Nevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Kuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8779-3220","authenticated-orcid":false,"given":"Craig M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Tulinius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique M.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9008-0208","authenticated-orcid":false,"given":"Diana","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9351-7054","authenticated-orcid":false,"given":"Richard S.","family":"Finkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren P.","family":"Morgenroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Shimony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Shale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetrib","family":"Hathout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanneboyina","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"van den Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-9185","authenticated-orcid":false,"given":"Leanne M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Ahmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaelyn R.","family":"Cornish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula R.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2018.09.007_bib0005","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.wnl.0000173836.09176.c4","article-title":"Early onset of inflammation and later involvement of TGFbeta in duchenne muscular dystrophy","volume":"65","author":"Chen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2018.09.007_bib0010","doi-asserted-by":"crossref","first-page":"299rv4","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2018.09.007_bib0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"CINRG investigators. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with duchenne muscular dystrophy: a prospective cohort study","volume":"391","author":"McDonald","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phrs.2018.09.007_bib0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"DMD care considerations working group. Diagnosis and management of duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2018.09.007_bib0025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00198-016-3774-5","article-title":"The time and determinants of first fractures in boys with duchenne muscular dystrophy","volume":"28","author":"Ma","year":"2017","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.phrs.2018.09.007_bib0030","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3233\/JND-160185","article-title":"European cross-sectional survey of current care practices for duchenne muscular dystrophy reveals regional and age-dependent differences","volume":"3","author":"Vry","year":"2016","journal-title":"J. Neuromuscul. Dis."},{"issue":"20","key":"10.1016\/j.phrs.2018.09.007_bib0035","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1212\/WNL.0000000000003217","article-title":"Efficacy and safety of deflazacort vs. Prednisone and placebo for duchenne muscular dystrophy","volume":"87","author":"Griggs","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.phrs.2018.09.007_bib0040","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.bmc.2013.02.009","article-title":"VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid","volume":"21","author":"Reeves","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.phrs.2018.09.007_bib0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.steroids.2018.02.010","article-title":"Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes","volume":"134","author":"Hoffman","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.phrs.2018.09.007_bib0050","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/emmm.201302621","article-title":"VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects","volume":"5","author":"Heier","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2018.09.007_bib0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/jpet.112.194340","article-title":"E.P. Hoffman. \u0394-9,11 modification of glucocorticoids dissociates nuclear factor-\u0138B inhibitory efficacy from glucocorticoid response element-associated side effects","volume":"343","author":"Baudy","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2018.09.007_bib0060","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41467-018-03780-1","article-title":"E.A. Ortlund. Cryptic glucocorticoid receptor-binding sites pervade genomic NF-\u03baB response elements","volume":"9","author":"Hudson","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2018.09.007_bib0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10571-014-0133-y","article-title":"VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis","volume":"35","author":"Dillingham","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2018.09.007_bib0070","doi-asserted-by":"crossref","first-page":"e63871","DOI":"10.1371\/journal.pone.0063871","article-title":"VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in mice","volume":"8","author":"Damsker","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.09.007_bib0075","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00011-016-0956-8","article-title":"VBP15, a novel dissociative steroid compound, reduces NFkB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis","volume":"65","author":"Damsker","year":"2016","journal-title":"Inflamm. Res."},{"issue":"August","key":"10.1016\/j.phrs.2018.09.007_bib0080","article-title":"Membrane stabilization by modified steroid offers a potential therapy for muscular dystrophy due to dysferlin deficit","author":"Sreetama","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2018.09.007_bib0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archneur.1975.00490440039005","article-title":"Response of serum creatine phosphokinase to steroid hormone","volume":"32","author":"Takahashi","year":"1975","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.phrs.2018.09.007_bib0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1530\/EJE-11-0751","article-title":"Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals","volume":"166","author":"Kauh","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.phrs.2018.09.007_bib0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12891-016-1135-3","article-title":"Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study","volume":"17","author":"Fleishaker","year":"2016","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.phrs.2018.09.007_bib0100","doi-asserted-by":"crossref","first-page":"31727","DOI":"10.1038\/srep31727","article-title":"Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children","volume":"6","author":"Hathout","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.phrs.2018.09.007_bib0105","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1038\/ctg.2016.49","article-title":"Identification of pathway-specific serum biomarkers of response to glucocorticoid and infliximab treatment in children with inflammatory bowel disease","volume":"7","author":"Heier","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.phrs.2018.09.007_bib0110","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/liv.13441","article-title":"The transformation in biomarker detection and management of drug-induced liver injury","volume":"37","author":"Church","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.phrs.2018.09.007_bib0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nmd.2013.09.004","article-title":"Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with duchenne muscular dystrophy: results of a double-blind randomized clinical trial","volume":"24","author":"Flanigan","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.phrs.2018.09.007_bib0120","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/0883073808314365","article-title":"Fidelity of gamma-glutamyl transferase (GGT) in differentiating skeletal muscle from liver damage","volume":"23","author":"Rosales","year":"2008","journal-title":"J. Child. Neurol"},{"key":"10.1016\/j.phrs.2018.09.007_bib0125","first-page":"CD008727","article-title":"Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia","volume":"11","author":"Rensen","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2018.09.007_bib0130","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/acr.23123","article-title":"Frequency and duration of adrenal suppression following glucocorticoid therapy in children with rheumatic diseases","volume":"69","author":"Ahmet","year":"2017","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.phrs.2018.09.007_bib0135","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2265.2007.03100.x","article-title":"Evaluation of adrenal function using the human corticotrophin-releasing hormone test, low dose synacthen test and 9am cortisol level in children and adolescents with central adrenal insufficiency","volume":"68","author":"Maguire","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.phrs.2018.09.007_bib0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1258\/0004563021901919","article-title":"Is a 0900-h serum cortisol useful prior to a short synacthen test in outpatient assessment?","volume":"39","author":"Le Roux","year":"2002","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.phrs.2018.09.007_bib0145","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.nmd.2007.05.008","article-title":"Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy","volume":"17","author":"S\u00f6derpalm","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.phrs.2018.09.007_bib0150","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jbmr.2756","article-title":"Histomorphometry and bone matrix mineralization before and after bisphosphonate treatment in boys with Duchenne muscular dystrophy: a paired transiliac biopsy study","volume":"31","author":"Misof","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.phrs.2018.09.007_bib0155","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-003-1443-y","article-title":"Bone mineral density and bone metabolism in duchenne muscular dystrophy","volume":"14","author":"Bianchi","year":"2003","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.phrs.2018.09.007_bib0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s002280050160","article-title":"Comparison of the pharmacodynamic effects of deflazacort and prednisolone in healthy subjects","volume":"51","author":"Babadjanova","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2018.09.007_bib0165","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/rheumatology\/kem030","article-title":"Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study","volume":"46","author":"Saviola","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.phrs.2018.09.007_bib0170","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/jbmr.410","article-title":"Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humans","volume":"26","author":"Rufo","year":"2011","journal-title":"J.\/ Bone Min. Res."},{"key":"10.1016\/j.phrs.2018.09.007_bib0175","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1073\/pnas.89.2.753","article-title":"Alpha-helical coiled-coil stalks in the low-affinity receptor for IgE (Fc epsilon RII\/CD23) and related C-type lectins","volume":"89","author":"Beavil","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2018.09.007_bib0180","doi-asserted-by":"crossref","first-page":"e4824","DOI":"10.1371\/journal.pone.0004834","article-title":"Molecular blocking of CD23 supports its role in the pathogenesis of arthritis","volume":"4","author":"Rambert","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.09.007_bib0185","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1189\/jlb.0106035","article-title":"Evidence that phospholipase-C-dependent, calcium-independent mechanisms are required for directional migration of T-lymphocytes in response to the CCR4 ligands CCL17 and CCL22","volume":"79","author":"Cronshaw","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phrs.2018.09.007_bib0190","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.autrev.2017.10.004","article-title":"Interleukin-22 in human inflammatory diseases and viral infections","volume":"16","author":"Shabgah","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.phrs.2018.09.007_bib0195","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.celrep.2015.07.066","article-title":"TNF-\u03b1-induced microRNAs control dystrophin expression in becker muscular dystrophy","volume":"12","author":"Fiorillo","year":"2015","journal-title":"Cell. Rep."},{"issue":"June","key":"10.1016\/j.phrs.2018.09.007_bib0200","article-title":"Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone","author":"Fiorillo","year":"2018","journal-title":"Phys. Genomics"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818309757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818309757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:53:30Z","timestamp":1760910810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661818309757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":40,"alternative-id":["S1043661818309757"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.09.007","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}